Artificial intelligence (AI) software provider EnvoyAI, advanced visualization firm TeraRecon, and U.K. PACS provider Insignia Medical Systems have announced a collaboration to offer AI-enhanced imaging workflows to U.K. clients.
The agreement will make AI content available on EnvoyAI's platform, including results viewing directly within the PACS viewer as well as within the already established Insignia integration with TeraRecon, the three firms said.
EnvoyAI is a spin-off formed by a 2017 TeraRecon acquisition of McCoy Medical Technologies. The three companies plan to highlight the integration in EnvoyAI's booth at the upcoming Society for Imaging Informatics in Medicine (SIIM) annual meeting in National Harbor, MD.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
